Nurix Therapeutics Inc. (NRIX) Financial Ratios & Valuation Metrics Analysis - P/E, ROE, Debt Ratios & Profitability - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Nurix Therapeutics Inc.

    NASDAQ: NRIX · Real-Time Price · USD
    8.93
    0.60 (7.20%)
    At close: Sep 26, 2025, 3:59 PM
    8.93
    0.00%
    After-hours: Sep 26, 2025, 04:20 PM EDT

    Nurix Therapeutics Ratios and Metrics

    Financials in USD. Fiscal year is December - November.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Nov 30, 2024 Nov 30, 2023 Nov 30, 2022 Nov 30, 2021
    PE Ratio
    		 -7.67 -2.35 -3.34 -10.55
    PEG Ratio
    		 -0.88 0.08 -0.09 9.70
    PS Ratio
    		 27.21 4.39 15.59 41.55
    PB Ratio
    		 2.82 1.69 1.98 3.61
    P/FCF Ratio
    		 -8.16 -3.77 -3.5 -13.73
    P/OCF Ratio
    		 -8.6 -4.15 -3.77 -14.65
    OCF/S Ratio
    		 -3.16 -1.06 -4.14 -2.84
    Debt / Equity Ratio
    		 0.05 0.15 0.04 0.04
    Quick Ratio
    		 6.46 3.40 4.52 4.70
    Current Ratio
    		 6.46 3.40 4.51 4.70
    Asset Turnover
    		 0.08 0.22 0.09 0.06
    Interest Coverage
    		 n/a n/a n/a n/a
    Return on Equity
    		 -0.37 -0.72 -0.59 -0.34
    Return on Assets
    		 -0.29 -0.4 -0.43 -0.25
    Return on Invested Capital
    		 -0.37 -0.56 -0.47 -0.28
    Dividend Yield
    		 n/a n/a n/a n/a
    Payout Ratio
    		 n/a n/a n/a n/a
    Gross Profit Margin
    		 0.70 0.82 0.72 0.80
    Net Profit Margin
    		 -3.55 -1.87 -4.67 -3.94
    Pretax Profit Margin
    		 -3.54 -1.87 -4.67 -3.93
    Operating Profit Margin
    		 -3.91 -2.01 -4.76 -3.96
    FCF Margin
    		 -3.33 -1.17 -4.45 -3.03
    EBITDA Margin
    		 -3.6 -1.84 -4.48 -3.76

    Add to Watchlist